When HNF1A-DM, GCK-DM, and MDM patients were pooled into one monogenic diabetes group, no differences in miR-122 levels were observed between this group and T1DM and T2DM patients and healthy controls. This evidence concerns the gene HNF1A and type 2 diabetes mellitus.